The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the underlying metabolic issues that contribute to the disease, said Sanyal, who is the lead author on the new paper and is also a professor of medicine at the VCU School of Medicine
We name providers we do not partner with where they earn the placement
Between high costs, insurance limitations, and potential side effects, these medications may not be the right fit for many
GLP-1 receptor agonists (such as Ozempic, Wegovy, and Rybelsus) and dual GLP-1/GIP receptor agonists like Mounjaro are medications originally designed to manage Type 2 diabetes but have also gained FDA approval for weight loss due to their significant impact on appetite regulation and metabolism
These medications are another reminder that obesity is a complex chronic disease influenced by biology, genetics, medications, sleep, stress, food environments, and social factors
2025 Aug:233:108610